10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,681 | +2.2% | 10,465 | +38.4% | 0.01% | 0.0% |
| Q2 2023 | $422,262 | +8.1% | 7,562 | +8.0% | 0.01% | +12.5% |
| Q1 2023 | $390,530 | +38.3% | 7,000 | -9.7% | 0.01% | +33.3% |
| Q4 2022 | $282,410 | -48.7% | 7,750 | -59.8% | 0.01% | -50.0% |
| Q3 2022 | $550,000 | -40.5% | 19,299 | -5.6% | 0.01% | -33.3% |
| Q2 2022 | $925,000 | -42.2% | 20,442 | -2.7% | 0.02% | -28.0% |
| Q1 2022 | $1,599,000 | -51.0% | 21,015 | -4.0% | 0.02% | -46.8% |
| Q4 2021 | $3,261,000 | +15.1% | 21,889 | +12.5% | 0.05% | +9.3% |
| Q3 2021 | $2,832,000 | -7.3% | 19,454 | +24.6% | 0.04% | -4.4% |
| Q2 2021 | $3,056,000 | +58.0% | 15,607 | +46.1% | 0.04% | +50.0% |
| Q1 2021 | $1,934,000 | +200.3% | 10,685 | +134.8% | 0.03% | +172.7% |
| Q4 2020 | $644,000 | – | 4,551 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |